• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

Smiths Medical warns on 8 potential issues with infusion pumps

July 13, 2022 By Sean Whooley

Smiths Medical

Smiths Medical issued an urgent field safety notice in Europe regarding its Medfusion 3500 and 4000 infusion pumps. The company issued the letter to notify on eight potential issues with its pumps. The issues include false alarms, unanticipated depleted battery alarms and abnormal circuit board behavior causing internal clock system failure. Additionally, issues with intermittent […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Recalls Tagged With: Smiths Medical

Readout Health wins JDRF grant to evaluate handheld breath ketone monitor

July 12, 2022 By Sean Whooley

Readout Health Biosense Device health app

Readout Health announced today that it entered into a sponsored research agreement with Washington University School of Medicine. The agreement with Washington University School of Medicine (St. Louis) includes a two-year, $360,000 research grant from JDRF to test the efficacy of the Biosense handheld breath ketone monitor in persons with type 1 diabetes during usual […]

Filed Under: Big Data, Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Patient Monitoring Tagged With: Juvenile Diabetes Research Foundation (JDRF), Readout Health

Vertex to acquire stem cell-derived diabetes treatment maker ViaCyte for $320M

July 11, 2022 By Sean Whooley

Vertex Pharmaceuticals ViaCyte

Vertex Pharmaceuticals (Nasdaq:VRTX) announced today that it agreed to acquire ViaCyte for $320 million. San Diego-based ViaCyte develops an advanced portfolio of novel stem cell-derived replacement therapies designed to provide a functional cure for patients with type 1 diabetes. Boston-based Vertex develops its own similar therapeutic for diabetes, having designed its VX-880 as a stem […]

Filed Under: Business/Financial News, Diabetes, Featured, Mergers & Acquisitions, Stem Cells Tagged With: Vertex Pharmaceuticals, ViaCyte

Zillion partners with Dexcom on CGM integration

July 7, 2022 By Sean Whooley

zillion Dexcom

Zillion announced today that it partnered with Dexcom (Nasdaq:DXCM) to integrate its CGM technology with Zillion’s digital health platform. Needham, Massachusetts-based Zillion will connect Dexcom’s continuous glucose monitoring (CGM) platform with its digital health offering for the RestoreHealth program, enhancing RestoreHealth for employer and health system patients. “Type 2 diabetes continues to be a growing […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom, Zillion

Senseonics announces equity grants to employees

July 6, 2022 By Sean Whooley

Senseonics Eversense E3 Ascensia Diabetes Care

Senseonics (NYSE:SENS) announced that it made equity grants to new employees under its 2019 inducement plan. Germantown, Maryland–based Senseonics, which develops the Eversense family continuous glucose monitoring (CGM) systems, including the latest-generation Eversense E3 180-day CGM, made the equity grants in accordance with the NYSE American Company Guide Section 711(a). On July 1, 2022, Senseoincs’ […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Wall Street Beat Tagged With: Senseonics

Lyra Therapeutics appoints new chief medical officer

July 5, 2022 By Sean Whooley

Lyra Therapeutics chief medical officer Richard Neiman

Lyra Therapeutics (Nasdaq:LYRA) announced today that it appointed Dr. Richard Nieman as its new chief medical officer (CMO). Nieman’s appointment as CMO of Lyra, which develops the XTreo — a platform for enabling precise, sustained and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues — will be […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Implants, Otolaryngology Ear, Nose & Throat, Personnel, Pharmaceuticals, Respiratory Tagged With: Lyra Therapeutics, Personnel, Personnel Moves

FDA lifts hold on Vertex’s insulin-producing cell therapy for diabetes

July 5, 2022 By Sean Whooley

Vertex Pharmaceuticals

Vertex Pharmaceuticals (Nasdaq:VRTX) announced today that the FDA lifted the clinical hold placed on the Phase 1/2 trial of VX-880. Boston-based Vertex designed VX-880 as a stem cell-derived fully differentiated pancreatic islet cell replacement therapy for people with type 1 diabetes with impaired hypoglycemic awareness and severe hypoglycemia. It could potentially restore the body’s ability […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceuticals Tagged With: Vertex Pharmaceuticals

Retractable Technologies declares dividends

July 1, 2022 By Sean Whooley

Retractable Technologies

Retractable Technologies (NYSE:RVP) announced that its board of directors declared dividends to holders of its convertible preferred stock. The dividends declared to holders of Retractable Technologies’ Series II Class B and Series III Class B convertible preferred stock totals amounts of $39,050 and $19,061.25, respectively. Dividends have accrued a $1 per share per annum and […]

Filed Under: Business/Financial News, Drug-Device Combinations, Wall Street Beat Tagged With: Retractable Technologies

Teva appoints former Vertex exec as new head of R&D, CMO

July 1, 2022 By Sean Whooley

Teva Pharmaceuticals Global R&D Chief Medical Officer CMO Eric A. Hughes

Teva Pharmaceuticals (NYSE:TEVA) announced today that it appointed Dr. Eric A. Hughes as VP of global R&D and chief medical officer. Hughes’ employment becomes effective Aug. 1, 2022, and he will be based out of Tel Aviv, Israel-based Teva’s U.S. headquarters in Parsippany, New Jersey. The company develops generic and specialty medicines, including inhalation solutions. […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Personnel, Pharmaceuticals, Technology Tagged With: Personnel, Personnel Moves, Teva, Teva Pharmaceuticals

West Pharmaceutical Services debuts new needle syringe system

July 1, 2022 By Sean Whooley

West Pharmaceutical Services Daikyo Crystal Zenith Insert Needle Syringe System

West Pharmaceutical Services (NYSE:WST) announced the recent unveiling of its Daikyo Crystal Zenith needle syringe system. Exton, Pennsylvania–based West designed the Daikyo Crystal Zenith 2.25mL insert needle syringe system as a technologically advanced cyclic olefin polymer containment and delivery system. It’s meant to offer an alternative to glass, mitigating the risk of breakage and reducing […]

Filed Under: Business/Financial News, Drug-Device Combinations, Pharmaceuticals Tagged With: West Pharmaceutical, West Pharmaceutical Services

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to page 7
  • Interim pages omitted …
  • Go to page 81
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS